These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 23034583

  • 1. Sublingual zolpidem (Edluar™; Sublinox™).
    Yang LP, Deeks ED.
    CNS Drugs; 2012 Nov; 26(11):1003-10. PubMed ID: 23034583
    [Abstract] [Full Text] [Related]

  • 2. A new sublingual formulation of zolpidem for the treatment of sleep-onset insomnia.
    Staner L, Danjou P, Luthringer R.
    Expert Rev Neurother; 2012 Feb; 12(2):141-53. PubMed ID: 22288669
    [Abstract] [Full Text] [Related]

  • 3. Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middle-of-the-night awakening in insomnia in a randomized, double-blind, placebo-controlled, outpatient study.
    Roth T, Krystal A, Steinberg FJ, Singh NN, Moline M.
    Sleep; 2013 Feb 01; 36(2):189-96. PubMed ID: 23372266
    [Abstract] [Full Text] [Related]

  • 4. Sublingual zolpidem in early onset of sleep compared to oral zolpidem: polysomnographic study in patients with primary insomnia.
    Staner C, Joly F, Jacquot N, Vlasova ID, Nehlin M, Lundqvist T, Edenius C, Staner L.
    Curr Med Res Opin; 2010 Jun 01; 26(6):1423-31. PubMed ID: 20397964
    [Abstract] [Full Text] [Related]

  • 5. Low-dose sublingual zolpidem tartrate is associated with dose-related improvement in sleep onset and duration in insomnia characterized by middle-of-the-night (MOTN) awakenings.
    Roth T, Hull SG, Lankford DA, Rosenberg R, Scharf MB, Intermezzo Study Group.
    Sleep; 2008 Sep 01; 31(9):1277-84. PubMed ID: 18788653
    [Abstract] [Full Text] [Related]

  • 6. Sublingual zolpidem is more effective than oral zolpidem in initiating early onset of sleep in the post-nap model of transient insomnia: a polysomnographic study.
    Staner L, Eriksson M, Cornette F, Santoro F, Muscat N, Luthinger R, Roth T.
    Sleep Med; 2009 Jun 01; 10(6):616-20. PubMed ID: 18996742
    [Abstract] [Full Text] [Related]

  • 7. Zolpidem's use for insomnia.
    Monti JM, Spence DW, Buttoo K, Pandi-Perumal SR.
    Asian J Psychiatr; 2017 Feb 01; 25():79-90. PubMed ID: 28262178
    [Abstract] [Full Text] [Related]

  • 8. Zolpidem extended-release.
    Moen MD, Plosker GL.
    CNS Drugs; 2006 Feb 01; 20(5):419-26; discussion 427-8. PubMed ID: 16696581
    [Abstract] [Full Text] [Related]

  • 9. Extended-release zolpidem: efficacy and tolerability profile.
    Owen RT.
    Drugs Today (Barc); 2006 Nov 01; 42(11):721-7. PubMed ID: 17171191
    [Abstract] [Full Text] [Related]

  • 10. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study.
    Krystal AD, Erman M, Zammit GK, Soubrane C, Roth T, ZOLONG Study Group.
    Sleep; 2008 Jan 01; 31(1):79-90. PubMed ID: 18220081
    [Abstract] [Full Text] [Related]

  • 11. Zolpidem extended-release: a single insomnia treatment option for sleep induction and sleep maintenance symptoms.
    Barkin RL.
    Am J Ther; 2007 Jan 01; 14(3):299-305. PubMed ID: 17515707
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: a randomized controlled trial.
    Maroo N, Hazra A, Das T.
    Indian J Pharmacol; 2013 Jan 01; 45(1):34-9. PubMed ID: 23543804
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
    Roth T, Soubrane C, Titeux L, Walsh JK, Zoladult Study Group.
    Sleep Med; 2006 Aug 01; 7(5):397-406. PubMed ID: 16815744
    [Abstract] [Full Text] [Related]

  • 14. Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial.
    Rosenberg R, Murphy P, Zammit G, Mayleben D, Kumar D, Dhadda S, Filippov G, LoPresti A, Moline M.
    JAMA Netw Open; 2019 Dec 02; 2(12):e1918254. PubMed ID: 31880796
    [Abstract] [Full Text] [Related]

  • 15. Gender influences on efficacy and safety of sublingual zolpidem tartrate for middle-of-the-night awakening in insomnia.
    Roth T, Steinberg F, Singh NN, Moline M.
    Hum Psychopharmacol; 2014 Jan 02; 29(1):25-30. PubMed ID: 24424704
    [Abstract] [Full Text] [Related]

  • 16. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
    Fava M, Asnis GM, Shrivastava RK, Lydiard B, Bastani B, Sheehan DV, Roth T.
    J Clin Psychiatry; 2011 Jul 02; 72(7):914-28. PubMed ID: 21208597
    [Abstract] [Full Text] [Related]

  • 17. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
    Scharf MB, Roth T, Vogel GW, Walsh JK.
    J Clin Psychiatry; 1994 May 02; 55(5):192-9. PubMed ID: 8071269
    [Abstract] [Full Text] [Related]

  • 18. Comparison of pharmacokinetic profiles of zolpidem buffered sublingual tablet and zolpidem oral immediate-release tablet: results from a single-center, single-dose, randomized, open-label crossover study in healthy adults.
    Greenblatt DJ, Harmatz JS, Roth T, Singh NN, Moline ML, Harris SC, Kapil RP.
    Clin Ther; 2013 May 02; 35(5):604-11. PubMed ID: 23541711
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of zolpidem extended release in elderly primary insomnia patients.
    Walsh JK, Soubrane C, Roth T.
    Am J Geriatr Psychiatry; 2008 Jan 02; 16(1):44-57. PubMed ID: 18165461
    [Abstract] [Full Text] [Related]

  • 20. Lower doses of sublingual Zolpidem are more effective than oral Zolpidem to anticipate sleep onset in healthy volunteers.
    Valente KD, Hasan R, Tavares SM, Gattaz WF.
    Sleep Med; 2013 Jan 02; 14(1):20-3. PubMed ID: 23218533
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.